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Abstract
Background: The effect of adherence to cardiac rehabilitation (CR) on outcome is not clear. Therefore, we aimed to
assess the impact of drop-out for non-medical reasons of CR on event-free survival in coronary artery disease (CAD).
Methods: A total of 876 patients who attended CR after acute coronary syndrome (ACS), percutaneous coronary
intervention (PCI) or coronary artery bypass graft (CABG) were included. Drop-out was defined as attending 50% of
the training sessions. A combined endpoint of all-cause mortality and rehospitalization for a cardiovascular event was
used to specify event-free survival. Differences in clinical characteristics were assessed and parameters with p< 0.10
were entered in a multiple Cox regression analysis.
Results: A total of 15% died or had a cardiovascular event during a median follow-up period of 33 months (interquartile
range 24, 51). Overall, 17% dropped out before finishing half of the program. Patients who withdrew prematurely had a
risk twice as high for a cardiovascular event or death (hazard ratio 1.92, 95% confidence interval 1.28–2.90) than those
who attended more than half of the sessions. Both ACS (2.36, 1.47–3.58) and PCI (2.20, 1.22–3.96), as primary indicators
for CR, were associated with an adverse outcome and also a prior history of chronic heart failure (CHF) remained
negatively associated with event-free survival (3.67, 1.24–10.91). Finally, the presence of hyperlipidemia was independ-
ently related to a worse outcome (1.48, 1.02–2.16).
Conclusions: Drop-out for non-medical reasons was independently associated with a negative outcome in CAD.
Therefore, underlying factors for drop-out should gain more attention in future research and should be taken into
account when organizing CR.
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Introduction
Cardiovascular disease remains the leading cause of
death, with coronary artery disease (CAD) and stroke
representing the largest burden.1 Cardiac rehabilitation
(CR) has been proven to be a valuable part of the treat-
ment of CAD and its secondary prevention, by having
beneﬁcial eﬀects on the risk factors and by substantially
decreasing mortality.2,3
However, participation in CR remains suboptimal4,5
with a substantial percentage of drop-out among those
who start attending CR.6–8 To date, the inﬂuence of
drop-out on the long-term cardiovascular outcome
has not been fully elucidated. It remains undetermined
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whether a higher number of attended training sessions
is associated with a better cardiovascular outcome.9–13
Some authors reported a signiﬁcant dose–response
relationship between the number of attended CR ses-
sions and the risk of death or a recurrent myocardial
infarction,9,10 while others stated that the eﬀect of CR
was independent on the dose of the exercise
intervention.11–13
Therefore, the primary aim of the present study was
to investigate the impact of drop-out in CR among
CAD patients on outcome 3 years later, with outcome
being deﬁned as the combined endpoint of death or
rehospitalization for a recurrent cardiovascular event.
Methods
Study population
A total of 1024 CAD patients who entered CR in two
hospitals between September 2007 and January 2013
were prospectively enrolled. Early withdrawal from
CR may be due to medical reasons, but may also be
the result of lack of motivation, problems to get to CR
or ﬁnancial restraints which is considered as drop-out
for non-medical reasons. Since drop-out for non-med-
ical reasons was the main focus, patients who dropped
out for medical reasons (n¼ 100, 10%) were excluded
from further analysis. The date of the patient’s ﬁrst CR
session served as the index date to determine the follow-
up period and the time to a cardiovascular event or
death. Overall, 48 of the 924 patients (5%) had a
limited follow-up period of less than 6 months after
start of CR and were deﬁned as lost to follow up, leav-
ing 876 patients for the outcome analysis. This ﬂow in
patient selection is presented in Figure 1. The selected
patient group started CR after acute coronary syn-
drome (ACS, n¼ 377, 43%), percutaneous coronary
intervention without preceding infarction (PCI,
n¼ 114, 13%) or coronary artery bypass graft
(CABG, n¼ 385, 44%).
Ethics
The study complied with the Declaration of Helsinki
and was approved by the ethical committee of the
two participating hospitals. Written informed consent
was obtained from all patients.
Cardiac rehabilitation
Each patient entered a multidisciplinary rehabilitation
program which was similar in both hospitals, consisting
of exercise training as a basis, supplemented with diet-
ary counseling, assistance to return to work, smoking
cessation or psychological support as needed. Patients
trained 2– or 3 times weekly for 60 minutes during
6 months after discharge from the hospital for their
primary event, with a maximum of 45 reimbursed ses-
sions according to national legislation. The supervised
training program consisted of a combination of endur-
ance and strengthening exercises. Endurance training
was performed at an intensity of the heart rate at the
anaerobic threshold and strengthening exercises pri-
marily targeted major upper and lower body muscles
at 60% of one repetition maximum. Progression was
re-evaluated approximately every 10 sessions. Body
weight and waist were measured at start and end of
CR and individual dietary counseling was oﬀered in
cases where patients were of overweight or on the
patient’s request. The need for assistance to return to
work was assessed for each patient individually.
Patients with an increased risk of anxiety or depression
according to the Hospital Anxiety and Depression
Scale14 were invited for individual psychological sup-
port and smoking cessation counselling was oﬀered to
active smokers at the moment of their cardiovascular
event. Apart from these individual sessions, group edu-
cational sessions concerning medical and psychological
aspects of a heart disease, a healthy diet and exercise
training were organized for free to provide general
information on these topics.
Because the length of phase II rehabilitation pro-
grams varies across countries, drop- – out was deﬁned
as attending 50% of the sessions or less, which is con-









Exclusion lost to follow-up
n=48 (5%)
Figure 1. Flow chart of the patient selection
CAD: coronary artery disease
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Demographic and clinical characteristics
In all patients, demographic and clinical characteristics
were collected at the start of CR, based on chart review.
Left ventricular ejection fraction (LVEF) was measured
on admission to the hospital for the primary event
according to the Simpson method15 in 838 patients
(96% of the study population). Patients were deﬁned
as having a history of chronic heart failure (CHF) if an
episode of decompensation was described in the
patient’s medical history.
Outcome
The main outcome was the combined endpoint of
all-cause mortality and rehospitalization for a recurrent
coronary event, cerebrovascular accident (CVA) or
CHF episode. Mortality data were obtained through
the governmental Crossroads Bank for Social
Security. Subsequent events were determined by search-
ing for the ﬁrst event occurring after the index date, as
mentioned in the hospital medical records. The length
of follow up used in the statistical regression analyses
was truncated at 3 years after the index date.
Statistical analysis
All statistical analyses were performed with SPSS
Statistics for Windows, version 24.0 (IBM). Data are
expressed as percentages (N) or mean standard devi-
ation for categorical and continuous variables respect-
ively. Diﬀerences between groups were examined with a
Chi-square test or Fisher’s exact test for categorical
variables and the independent-samples Student’s t-test
or Mann–Whitney U test for continuous variables.
First, the general characteristics were compared
between patients who were deﬁned as ‘lost to follow
up’ and those who were included in further analyses.
Thereafter, diﬀerences in clinical characteristics accord-
ing to event-free survival were analyzed. Variables with
an overall signiﬁcance value of p< 0.10 were entered in
a multiple Cox regression analysis to identify the stron-
gest predictors for event-free survival. Parameter esti-
mation was conducted via the maximum likelihood
method; exp(B) and the corresponding 95% conﬁdence
interval (CI) was obtained as the estimated hazard ratio
(HR). Normality and linearity of the continuous vari-
ables in the Cox regression analysis were checked and
no major deviations were observed. A visual inspection
of the log minus log plots was also performed to check
whether the proportional hazards assumption was met,
which was fulﬁlled in this analysis. An additional boot-
strap analysis was performed, which did not result in
changes in signiﬁcance levels of the variables in the ﬁnal
analysis and thus may indicate the stability of the
obtained results. Finally, a survival plot corrected for
the confounders was drawn according to drop-out.
Results
Baseline characteristics
Baseline characteristics of the study population
(n¼ 876) are summarized in Table 1. CAD patients
were on average 61 years old and the majority (84%)
of them were men with a preserved LVEF. A total of
43% were included in CR after ACS and 44% after
CABG. Only 13% started CR after PCI without pre-
ceding ACS. Almost half of the CAD population were
known to have hypertension and hyperlipidemia and
17% suﬀered from diabetes. Comorbidities such as
chronic obstructive pulmonary disease (COPD), CVA
and peripheral arterial disease (PAD) were only present
in a minority of the patients (<10%) but 18% of them
had a prior history of CAD. The whole study popula-
tion attended on average 36 11 training sessions, and
17% stopped prematurely after 15 6 sessions.
Comparison between the study population and
patients who were lost to follow up
No marked diﬀerences in clinical characteristics could
be observed when comparing the ﬁnal study sample
(n¼ 876) with the patients who were excluded for a
limited follow-up period (n¼ 48), except for the pri-
mary index event. A higher percentage of patients
after an elective PCI procedure (25% versus 13%,
p< 0.05) were lost to follow up. Patients who were
lost to follow up were also more frequently diagnosed
with hyperlipidemia (65% versus 47%, p< 0.05). These
results are shown in Supplement 1.
Comparison according to drop-out
Clinical characteristics were also compared between the
groups with high versus low adherence. Since this was
not the main objective of this study, results are shown
in Supplement 2 but not further described in detail.
Multiple predictors for event-free survival
The diﬀerences in demographic and clinical characteristics
according to event-free survival are presented in Table 1.
Overall, 15% of the CAD patients (n¼ 132) had a recur-
rent event or deceased during a median follow-up period
of 33 months (interquartile range 24, 51). Patients who
had an event had a slightly lower left ventricular function
(p< 0.05), were more frequently diagnosed with ACS or
elective PCI than with CABG (p< 0.001), suﬀered more
from hyperlipidemia (p< 0.05) or had a prior history of
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CHF (p< 0.05). In addition, there was a trend towards a
higher use of angiotensin converting enzyme (ACE)
inhibitors or angiotensin receptor blockers (ARBs;
p¼ 0.06). A signiﬁcantly higher drop-out rate was
recorded in this group with recurrent events compared
with those who had an event-free survival (27% versus
16%, p< 0.001).
Since the absolute number of sessions and drop-out
were signiﬁcantly related parameters, drop-out was
solely included in the multiple Cox regression analysis
which is shown in Table 2. Besides parameters with a
p-value< 0.10, demographic characteristics were also
added to correct for possible diﬀerences in baseline
characteristics. Using multiple analysis, LVEF and
the use of ACE inhibitors or ARB were no longer
signiﬁcant predictors, but the primary index event
turned out to be an important factor. Patients who
started CR after ACS (HR 2.36, 95% CI 1.47–3.80,
p< 0.001) or PCI (HR 2.20, 95% CI 1.22–3.95,
p< 0.01) had twice as much risk to have a recurrent





CV event or death
n¼ 132 p-value
Age (years): mean SD 61.4 9.9 61.4 9.9 61.5 9.8 0.85
Men: % (N) 84.1 (737) 84.1 (626) 84.1 (111) 1.00
BMI (kg/m2): mean SD 27.2 3.9 27.2 3.9 27.2 3.9 0.90
LVEF (%): mean SD (n¼ 838) 61.6 14.3 62.0 14.2 58.9 15.1 <0.05*
Exercise training after: % (N) < 0.001***
ACS 43.2 (378) 40.7 (303) 56.8 (75)
Elective PCI 13.0 (114) 12.5 (93) 15.9 (21)
CABG 43.8 (384) 46.8 (348) 27.3 (36)
Risk factors and comorbidities: % (N)
Hypertension 48.9 (428) 48.8 (363) 49.2 (65) 0.92
Hyperlipidemia 47.3 (414) 45.8 (341) 55.3 (73) <0.05*
Diabetes 17.4 (152) 17.1 (127) 18.9 (25) 0.62
Smoking at start CR 7.4 (65) 7.0 (52) 9.8 (13) 0.28
COPD (n¼ 456) 5.3 (24) 4.5 (17) 9 (7) 0.16
CVA 2.7 (24) 2.6 (19) 3.8 (5) 0.39
PAD 5.6 (49) 5.2 (39) 7.6 (10) 0.30
AF at start CR 2.6 (23) 2.7 (20) 2.3 (3) 1.00
Prior CAD: % (N) 18.3 (160) 18.0 (134) 19.7 (26) 0.71
Prior CHF: % (N) 1.1 (10) 0.8 (6) 3.0 (4) <0.05*
Medication: % (N)
Antiplatelets 98.5 (863) 98.5 (733) 98.5 (130) 1.00
Anticoagulants 11.3 (99) 11.2 (83) 12.1 (16) 0.77
Lipid lowering drugs 93.3 (817) 93.1 (693) 93.9 (124) 0.85
Beta blockers 87.6 (767) 88.3 (657) 83.3 (110) 0.12
ACE inhibitors/ARB 46.9 (411) 45.6 (339) 54.5 (72) 0.06
Diuretics 14.8 (130) 14.9 (111) 14.4 (19) 0.90
Spironolactone 7.8 (68) 7.4 (55) 9.8 (13) 0.38
Number of training sessions: mean SD 36.4 11.3 36.9 10.9 33.7 13.1 <0.01**
Drop-out23 sessions: % (N) 17.2 (151) 15.5 (115) 27.3 (36) <0.001***
Frequency training program: % (N) 0.73
2/week 36.6 (318) 36.3 (267) 38.9 (51)
3/week 63.3 (549) 63.7 (469) 61.1 (80)
Categorical variables are presented as a percentage (%) and absolute number (N), continuous variables as mean SD.
ACE: angiotensin converting enzyme; ACS: acute coronary syndrome; AF: atrial fibrillation; ARB: Angiotensin Receptor Blockers; BMI: body mass
index; CABG: coronary artery bypass graft; CAD: coronary artery disease; CHF: chronic heart failure; COPD: chronic obstructive pulmonary disease;
CR: cardiac rehabilitation; CV: cardiovascular; CVA: cerebrovascular accident; LVEF: left ventricular ejection fraction; PCI: percutaneous coronary
intervention; PAD: peripheral arterial disease; SD: standard deviation.
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event or to die than those who had CABG. The pres-
ence of hyperlipidemia and a prior history of CHF
were also independently related with a higher event
rate (HR 1.48, 95% CI 1.02–2.16 and HR 3.67, 95%
CI 1.24–10.91 respectively, all p< 0.05). Drop-out was
a ﬁnal independent predictor with those who dropped
out in the ﬁrst half of the sessions being almost twice
as likely to have a recurrent event (HR 1.92, 95% CI
1.28–2.90, p< 0.01).
Figure 2 shows the survival plot for the combined
event of mortality and rehospitalization according to
drop-out, corrected for the confounders in the Cox
regression model with a higher event rate for patients
who withdrew early in the program.
Discussion
This study, based on a contemporary rehabilitation
registry of heterogeneous CAD patients, provides evi-
dence that early withdrawal from CR is independently
associated with a worse outcome in the long term.
We demonstrated that drop-out of CR almost doubled
the risk to die or to have a recurrent cardiovascular
event in this patient cohort.
Early withdrawal – deﬁned as attending less than
half of the sessions – was present in 17% of our patient
population, which is in line with previous observa-
tions.6,8 Our ﬁnding supports the results of Hammill
et al.10 who demonstrated a signiﬁcant dose–response
relationship between the attended number of CR
sessions and the risk of death and myocardial infarction
at 4 years. This dose–response eﬀect was further con-
ﬁrmed by Suaya et al.9, but other studies failed to ﬁnd
this dose–response relationship upon survival.11,12 This
discrepancy may be due to the diﬀerentiation in the
number of training sessions according to the patient’s
health status which is applied in some studies,11 allow-
ing ‘ﬁtter’ patients to graduate earlier than sick patients
with a higher number of sessions actually reﬂecting a
poorer health status. In our study, each patient had the
right to attend a similar amount of sessions, irrespective
of health status which makes a comparison on the
impact of drop-out more justiﬁed. Whereas a short
intensive rehabilitation program immediately amelior-
ates exercise capacity, a higher amount of sessions may
be needed to induce persistent lifestyle changes which
improves outcome in the long term.
Apart from early withdrawal, an indication of ACS
or elective PCI for CR doubled the risk for an adverse
event in comparison with patients participating in CR
after CABG. At ﬁrst glance, this ﬁnding may indirectly
reﬂect the higher rate of recurrent ACS or PCI proced-
ures seen among post-PCI patients. Lee et al.16 recently
reported that CABG, as compared with PCI, reduced
long-term rates of the composite measure of all-cause
death, myocardial infarction or stroke in patients with
CAD (13% versus 16%; HR 0.83, 95% CI 0.69–1.00,
p¼ 0.046).16 Another explanation could be that a larger
beneﬁt from CR is obtained in patients after
CABG.11,17 Of note, patients undergoing CABG have
more severe CAD and risk factors, which means they
may beneﬁt more from CR than patients with more
limited CAD.11 Whether this larger beneﬁt from CR
may have inﬂuenced outcome and events in this
cohort remains undetermined, but may be the subject
of further studies. In addition, the adherence rate for
CR may be higher in CABG patients as they perceive a
larger need for CR due to the impact of surgery.6,18
A prior history of CHF turned out to be independ-
ently related with a worse cardiovascular outcome after
following CR, which is not surprising given the known
detrimental impact of CHF on prognosis.19 Left ven-
tricular function on the other hand, did not predict
outcome. This is partly consistent with some previous
reports concerning outcome after hospitalization for
CHF.20 Nevertheless, other studies mentioned a
higher mortality rate among CHF patients with a
reduced ejection fraction as compared with those with
a preserved ejection fraction.19
With the exception of hyperlipidemia, the presence
of risk factors and comorbidities did not appear to play
a key role in event-free survival. In spite of the high
percentage of statin prescription in our patient group,
hyperlipidemia remained independently associated with
a worse outcome. This ﬁnding is in accordance with
Table 2. Multiple Cox regression analysis for event – free sur-





Age 1.01 0.99–1.03 0.41
Sexa 0.91 0.56–1.48 0.71
BMI 0.98 0.93–1.03 0.34
LVEF 0.99 0.98–1.01 0.43
Exercise training after:b <0.001***
ACS 2.36 1.47–3.80 <0.001***
Elective PCI 2.20 1.22–3.95 <0.01**
Hyperlipidemia 1.48 1.02–2.16 <0.05*
Prior CHF 3.67 1.24–10.91 <0.05*
ACE inhibitors/ARBs 1.10 0.74–1.66 0.64
Drop-out 23 sessions 1.92 1.28–2.90 <0.01**
amen: reference category
bcoronary artery bypass graft surgery: reference category
ACE: angiotensin converting enzyme; ACS: acute coronary syndrome;
ARB: angiotensin receptor blocker; BMI: body mass index; CHF: chronic
heart failure; LVEF: left ventricular ejection fraction; PCI: percutaneous
coronary intervention.
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existing literature demonstrating a high residual risk for
recurrent cardiovascular events despite the use of sta-
tins in ACS patients.21 Nevertheless, other comorbid-
ities such as COPD were not related to a worse
outcome which seems somewhat surprising since it
may have a detrimental impact on outcome.22–25 The
low prevalence of this latter comorbidity in our study
(i.e. less than 10%), may explain this discrepancy.
Given the known relationship between the number
of sessions and the subsequent outcome in the long
term, Hamill et al.10 suggested that it would be worth-
while to investigate the underlying reasons for lack of
adherence to attend the full course of CR. In our
previous work,7 which was based on the same rehabili-
tation registry, we demonstrated that mainly the pres-
ence of comorbidities and a vulnerable psychosocial
background played a key role in drop-out. The pres-
ence of comorbidities on top of the cardiac disease
involved a signiﬁcantly higher risk of early withdrawal.
Dependency for transport, but not the distance to the
CR center, was also a major predictor for drop-out.
Together with the associated risk of having no partner,
this suggests that a vulnerable social situation is
more important than logistic barriers. Furthermore,
the presence of symptoms of anxiety and depression
was another major determinant of drop-out, thereby
indicating the need for a multidisciplinary approach
in CR targeting not only the physical but also the
mental aspects of wellbeing.7
Limitations
Our study has some limitations. First, data related to
recurrent cardiovascular events were limited to the
information available in the hospital medical records.
Therefore, data on patients treated elsewhere were not
included in our analysis and may have led to an under-
estimation of the actual event rate. In addition, 5% of
patients were lost to follow up during the ﬁrst 6 months
after starting CR. Nevertheless, no major diﬀerences in
clinical characteristics were revealed making it unlikely
that this relatively low percentage of lost to follow up
may have inﬂuenced the outcome analysis. However,
one diﬀerence draws the attention, which is the higher
percentage of patients with elective PCI among those
who were lost to follow up. A plausible reason may be
the frequent referral of peripheral centers for PCI pro-
cedures to the two participating hospitals in this cohort
but with a further follow up and treatment of the
patient in the peripheral center after the procedure.
Thirdly, because of the limited available data on psy-
chosocial characteristics in our registry, these variables
could not be included in the multiple regression analysis
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Figure 2. Event-free survival according to drop-out.
This graph presents the event-free survival according to the number of attended sessions in cardiac rehabilitation, truncated at 3 years
after starting cardiac rehabilitation.
Pardaens et al. 1495
of adherence to CR on outcome was independent of
psychosocial background or not. In addition, the
underlying psychosocial reasons for drop-out should
be investigated more thoroughly since this is still an
important gap in the current literature.
As addressed in this study, adherence to CR was not
the sole mechanism to explain the reduced risk of mor-
tality and recurrent events, also other factors may play
an important role. From our results, we could not dis-
tinguish whether the beneﬁcial eﬀect of adherence to
CR on outcome was due to the training eﬀect itself or
rather indirectly reﬂected healthier behavior, thereby
lowering the risk for recurrent events which should
also be taken into account in further studies.
Conclusion
Drop-out for non-medical reasons was independently
associated with an adverse outcome in CAD, with a
higher event rate for the combined endpoint of mortal-
ity and recurrent cardiovascular events among those
patients who withdrew prematurely from CR.
Therefore, underlying factors for drop-out should
gain more attention in future research and should be
taken into account when organizing CR in order to
increase adherence to rehabilitation.
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